BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10193948)

  • 1. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2.
    Kallakury BV; Sheehan CE; Rhee SJ; Fisher HA; Kaufman RP; Rifkin MD; Ross JS
    Cancer; 1999 Apr; 85(7):1569-76. PubMed ID: 10193948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.
    Kallakury BV; Ambros RA; Hayner-Buchan AM; Sheehan CE; Malfetano JH; Ross JS
    Int J Gynecol Pathol; 1998 Oct; 17(4):320-6. PubMed ID: 9785132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
    Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
    Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p120, Ki-67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value.
    Bantis A; Giannopoulos A; Gonidi M; Liossi A; Aggelonidou E; Petrakakou E; Athanassiades P; Athanassiadou P
    Cytopathology; 2004 Feb; 15(1):25-31. PubMed ID: 14748788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings.
    Botticelli AR; Casali AM; Botticelli L; Zaffe D
    Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of biomarkers in paired primary and recurrent colorectal adenocarcinomas.
    Seong J; Chung EJ; Kim H; Kim GE; Kim NK; Sohn SK; Min JS; Suh CO
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1167-73. PubMed ID: 10613309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions.
    Tran TA; Ross JS; Carlson JA; Mihm MC
    Hum Pathol; 1998 Oct; 29(10):1085-90. PubMed ID: 9781646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genesis and evolution of high-ploidy tumour cells evaluated by means of the proliferation markers p34(cdc2), cyclin B1, PCNA and 3[H]-thymidine.
    Baroja A; de la Hoz C; Alvarez A; Ispizua A; Bilbao J; de Gandarias JM
    Cell Prolif; 1996 Feb; 29(2):89-100. PubMed ID: 8630339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p120 and AgNOR nucleolar protein expression: a comparison with nuclear proliferation markers in oral pathology.
    Migaldi M; Criscuolo M; Zunarelli E; Lo Bianco L; Martinelli AM; Barbolini G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Feb; 85(2):189-96. PubMed ID: 9503455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.
    Kourea HP; Koutras AK; Scopa CD; Marangos MN; Tzoracoeleftherakis E; Koukouras D; Kalofonos HP
    Mol Pathol; 2003 Dec; 56(6):328-35. PubMed ID: 14645695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer.
    Scott IS; Morris LS; Bird K; Davies RJ; Vowler SL; Rushbrook SM; Marshall AE; Laskey RA; Miller R; Arends MJ; Coleman N
    J Pathol; 2003 Oct; 201(2):187-97. PubMed ID: 14517835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor.
    Suzuki T; Urano T; Miki Y; Moriya T; Akahira J; Ishida T; Horie K; Inoue S; Sasano H
    Cancer Sci; 2007 May; 98(5):644-51. PubMed ID: 17359284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between cyclin B1 overexpression and lymph node metastasis in human colorectal cancer.
    Korenaga D; Takesue F; Yasuda M; Honda M; Nozoe T; Inutsuka S
    Surgery; 2002 Jan; 131(1 Suppl):S114-20. PubMed ID: 11821797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
    Cher ML; Chew K; Rosenau W; Carroll PR
    Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.
    Bozlu M; Orhan D; Baltaci S; Yaman O; Elhan AH; Tulunay O; Müftüoğlu YZ
    Int Urol Nephrol; 2002; 33(1):59-66. PubMed ID: 12090340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location of cell cycle regulators cyclin B1, cyclin A, PCNA, Ki67 and cell cycle inhibitors p21, p27 and p57 in human first trimester placenta and deciduas.
    Korgun ET; Celik-Ozenci C; Acar N; Cayli S; Desoye G; Demir R
    Histochem Cell Biol; 2006 Jun; 125(6):615-24. PubMed ID: 16491347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
    Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Ki-67 and PCNA as proliferating markers in prostate cancer.
    Sulik M; Guzińska-Ustymowicz K
    Rocz Akad Med Bialymst; 2002; 47():262-9. PubMed ID: 12533969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.